Advances in Diagnosis and Treatment for Thymic Pathology
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 10 April 2026 | Viewed by 1
Special Issue Editor
Interests: thymic tumors; thymic pathology; thymic surgery; mediastinal tumors; thymic immunobiology; tracheal surgery; NSCLC surgery after neoadjuvant immunochemotherapy
Special Issue Information
Dear Colleagues,
This Special Issue, entitled “Advances in Diagnosis and Treatment for Thymic pathology”, includes information related to this current hot topic. It is well known that thymic pathology interferes with the immunobiology of myasthenia gravis (MG); therefore, thymectomy is sometimes recommended in MG patients.
Furthermore, the oncology of the thymus is heterogenous; histological classification has significantly changed and TNM staging has been introduced. However, many issues still remain open to discussion.
Multidisciplinary collaboration is essential for organizing treatment planning and optimizing outcomes. Neurologists, oncologists, pathologists, thoracic surgeons, and immunologists are all involved in this procedure.
There are many particularities in this “neglected” gland that was once considered inactive; however, it is actually related to many disorders. The medical literature has recently examined thymic pathology. Our ambition is to cover the clinical aspects of thymic pathology and enlighten potential clinicians’ misunderstanding.
Dr. Charalambos Zisis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunobiology
- myasthenia gravis
- thymoma
- thymic carcinoma
- thymic hyperplasia
- paraneoplastic disorders
- histology
- classification
- staging, Masaoka
- autoimmune disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
